Sharechat Logo

AMP Capital to sell 18 NZ properties worth more than $1B to Canadian institutional investor

Thursday 10th July 2014

Text too small?

AMP Capital Investors has agreed to sell 18 New Zealand properties worth more than $1 billion to Canada's Public Sector Pension Investment Board.

The sale, which is subject to Overseas Investment Office approval, "highlights the strength of the New Zealand economy and its status as an attractive investment destination," AMP Capital Property Portfolio general manager Stephen Costley said in a statement. AMP Capital will continue to provide management services for the portfolio, which includes commercial office, industrial, retail and development properties across New Zealand.

The properties include large retail assets such as the 60,000-square metre Botany Town Centre and the 40,000-square metre Manukau Supa Centre as well as the 13-level PricewaterhouseCoopers Tower and adjoining 12,600-square metre Capital on the Quay retail facility in Wellington.

The sale allows AMP Capital Property Portfolio investors to realise their long-term investment in the portfolio, the investment manager said.

Macquarie Capital and PwC assisted the vendors in the sale.

 

 

 

 

BusinessDesk.co.nz



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

December 27th Morning Report
FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors